Charity vows to push for access to asthma drug, rejected by NICE

Asthma UK insists dupilumab, newest biologic for severe asthma, is ‘life-changing’ Related items fromOnMedica Prescription charge rise ‘puts asthma patient at risk’ New treatment option for severe asthma Good evidence for sublingual immunotherapy Doctors unite with campaigners in calling for smokefree 2030 Paracetamol use in infancy linked to asthma risk
Source: OnMedica Latest News - Category: UK Health Source Type: news